-
I125338-100mgIstradefylline(KW6002) is a very potent, selective and orally active adenosine A2A receptor antagonist(Ki=2.2 nM) in experimental models of Parkinson's disease.A selective A(2A) antagonist used to study parkinson’s disease in vitro.
-
I125338-1gIstradefylline(KW6002) is a very potent, selective and orally active adenosine A2A receptor antagonist(Ki=2.2 nM) in experimental models of Parkinson's disease.A selective A(2A) antagonist used to study parkinson’s disease in vitro.
-
I125338-25mgIstradefylline(KW6002) is a very potent, selective and orally active adenosine A2A receptor antagonist(Ki=2.2 nM) in experimental models of Parkinson's disease.A selective A(2A) antagonist used to study parkinson’s disease in vitro.
-
I125338-5mgIstradefylline(KW6002) is a very potent, selective and orally active adenosine A2A receptor antagonist(Ki=2.2 nM) in experimental models of Parkinson's disease.A selective A(2A) antagonist used to study parkinson’s disease in vitro.
-
-
-
I413838-100mgItacitinib (INCB39110).
-
I413838-10mgItacitinib (INCB39110).
-
I413838-250mgItacitinib (INCB39110).
-
I413838-25mgItacitinib (INCB39110).
-
I413838-50mgItacitinib (INCB39110).
-
I413838-5mgItacitinib (INCB39110).